AIDS preclinical vaccine development: Biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates

Journal of Medical Primatology

Volumn 28, Issue 4-5, 1999, Pages 249-273

  Warren, Jonathan T ^a   Levinson, Mark A ^a  

^a EMMES CORPORATION   (United States)

Author keywords

AIDS Vaccine Surveillance System (AVSS); Chimpanzee(s); HIV; Macaque(s); SHIV; SIV

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL; ARTICLE; DISEASE MODEL; FACTUAL DATABASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFORMATION PROCESSING; MONKEY DISEASE; PRIMATE; RESEARCH; SIMIAN IMMUNODEFICIENCY VIRUS;

AIDS VACCINES; ANIMALS; DATA COLLECTION; DATABASES, FACTUAL; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; HUMANS; PRIMATES; RESEARCH; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0033176773     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.1999.tb00276.x     Document Type: Article

References (73)

1. ABIMIKU AG, ROBERT-GUROFF M, BENSON J, TARTAGLIA J, PAOLETTI E, MARKHAM PD, FRANCHINI G: Long-term survival of SIVmac251-infected macaques previously immunized with NYVAC-SIV vaccines. J AIDS Hum Retrovirol 15(Suppl):S78-S85, 1997.
2. ABIMIKU AG, FRANCHINI G, TARTAGLIA J, ALDRICH K, MYAGKIKH M, MARKHAM PD, CHONG P, KLEIN M, KIENY M-P, PAOLETTI E, GALLO RC, ROBERT-GUROFF M: HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques. Nat Med 1:321-329, 1995.
3. ALMOND N, HEENEY JL: AIDS vaccine development in primate models. AIDS 12(Suppl A):S133-S140, 1998.
4. ALMOND N, CORCORAN T, HULL R, WALKER B, ROSE J, SANGSTER R, SILVERA K, SILVERA P, CRANAGE M, RUD E, STOTT EJ: Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells. J Med Primatol 26:34-43, 1997.
5. ALMOND N, ROSE J, SANGSTER R, SILVERA P, STEBBINGS R, WALKER B, STOTT EJ: Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. J Gen Virol 78:1919-1922, 1997.
6. BARNETT SW, KLINGER JM, DOE B, WALKER CM, HANSEN L, DULIEGE A-M, SINANGIL FM: Prime-boost immunization strategies against HIV. AIDS Res Hum Retroviruses 14(Suppl 3):S299-S309, 1998.
7. BEER B, BAIER M, MEGEDE JZ, NORLEY S, KURTH R: Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo. Proc Natl Acad Sci 94:4062-4067, 1997.
8. BENSON J, CHOUGNET C, ROBERT-GUROFF M, MONTEFIORI D, MARKHAM P, SHEARER G, GALLO RC, CRANAGE M, PAOLETTI E, LIMBACH K, VENZON D, TARTAGLIA J, FRANCHINI G: Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIVmac251: dependence on route of challenge exposure. J Virol 72:4170-4182, 1998.
9. BERGLUND P, QUESADA-ROLANDER M, PUTKONEN P, BIBERFELD G, THORSTENSSON R, LILJESTROM P: Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest Virus encoding human immunodeficiency virus type I envelope protein and challenge with a high dose of SHIV-4 virus. AIDS Res Hum Retroviruses 13:1487-1495, 1997.
10. BOYER JD, UGEN KE, CHATTERGOON M, WANG B, SHAH A, AGADJANYAN M, BARGARAZZI ML, JAVADIAN A, CARRANO R, CONEY L, WILLIAMS WV, WEINER DB: DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees. J Infect Dis 176:1501-1509, 1997.
11. BOYER JD, UGEN KE, WANG B, AGADJANYAN M, GILBERT L, BARGARAZZI ML, CHATTERGOON M, FROST P, JAVADIAN A, WILLIAMS WV, REFAELI Y, CICCARELLI RB, MCCALLUS D, CONEY L, WEINER DB: Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 3:526-532, 1997.
12. BOYER JD, WANG B, UGEN KE, AGADJANYAN M, JAVADIAN A, FROST P, DANG K, CARRANO RA, CICCARELLI R, CONEY L, WILLIAMS WV, WEINER DB: In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 25:242-250, 1996.
13. BUGE SL, RICHARDSON E, ALIPANAH S, MARKHAM P, CHENG S, KALYAN N, MILLER CJ, LUBECK M, UDEM S, ELDRIDGE J, ROBERT-GUROFF M: An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. J Virol 71:8531-8541, 1997.
14. COLE KS, ROWLES JL, JAGERSKI BA, MURPHEY-CORB M, UNANGST T, CLEMENTS JE, ROBINSON J, WYAND MS, DESROSIERS RC, MONTELARO RC: Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol 71:5059-5079, 1997.
15. CONNER RI, MONTEFIORI DC, BINLEY JM, MOORE JP, BONHOEFFER S, GETTIE A, FENAMORE EA, SHERIDAN KE, HO DD, DAILEY PJ, MARX PA: Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Virol 72:7501-7509, 1998.
16. CRANAGE M, COOK N, SHARPE S, DENNIS M, WHATMORE A, LEECH S, HALL G, RUD E: Intrarectal challenge of rhesus macaques infected with live attenuated SIVmac. J Med Primatol 23:239, 1994.
17. CRANAGE MP, SHARPE S, WHATMORE AM, POLYANSKAYA N, NORLEY S, COOK N, LEECH S, DENNIS M, HALL GA: In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose. J Gen Virol 79:1935-1944, 1998.
18. CRANAGE MP, WHATMORE AM, SHARPE SA, COOK N, POLYANSKAYA N, LEECH S, SMITH JD, RUD EW, DENNIS MJ, HALL GA: Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology 229:143-154, 1997.
19. DITTMER U, STAHL-HENNIG C, COULIBALY C, NISSLEIN T, LUKE W, FUCHS D, BODEMER W, PETRY H, HUNSMANN G: Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high dose SIV challenge. J Gen Virol 76:1307-1315, 1995.
20. DONAHUE RE, BUNNELL BA, ZINK MC, METZGER ME, WESTRO RP, KIRBY MR, UNANGST T, CLEMENTS JE, MORGAN RA: Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes. Nat Med 4:181-186, 1998.
21. DUNN CS, HURTREL B, BEYER C, GLOECKLER L, LEDGER TN, MOOG C, KIENY MP, MEHTALI M, SCHMITT D, GUT JP, KIRN A, AUBERTIN AM: Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type I. AIDS Res Hum Retroviruses 13:913-922, 1997.
22. FORESMAN L, JIA F, LI Z, WANG C, STEPHENS EB, SAHNI M, NARAYAN O, JOAG SV: Neutralizing antibodies administered before, but not after, virulent SHIV prevent infection in macaques. AIDS Res Hum Retroviruses 14:1035-1043, 1998.
23. FULLER DH, SIMPSON L, COLE KS, CLEMENTS JE, PANICALI DL, MONTELARO RC, MURPHEY-CORB M, HAYNES JR: Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol Cell Biol 75:389-396, 1997.
24. GIAVEDONI LD, AHMAD S, JONES L, YILMA T: Expression of gamma interferon by simian deficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J Virol 71:866-872, 1997.
25. GIAVEDONI LD, YILMA T: Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. J Virol 70:2247-2251, 1996.
26. GIRARD M, VAN DER RYST E, BARRE-SINOUSSI F, NARA P, TARTAGLIA J, PAOLETTI E, BLONDEAU C, JENNINGS M, VERRIER F, MEIGNIER B, FULTZ PN: Challenge of chimpanzees immunized with a recombinant Canarypox-HIV-1 virus. Virol 232:98-104, 1997.
27. GUNDLACH BR, REIPRICH S, SOPPER S, MEANS RE, DITTMER U, MATZ-RENSING K, STAHL-HENNIG C, UBERLA K: Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines. J Virol 72:7846-7851, 1998.
28. HAAFT PT, VERSTREPEN B, UBERLA K, ROSENWORTH B, HEENEY J: A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol 72:10281-10285, 1998.
29. HAIGWOOD NL, PIERCE CC, ROBERTSON MN, WATSON AJ, MONTEFIORI DC, RABIN M, LYNCH JB, KULLER L, THOMPSON J, MORTON WR, BENVENISTE RE, HU S-L, GREENBERG P, MOSSMAN SP: Protection from pathogenic SIV challenge using multigenic DNA vaccines. Immunol Letters 66:183-188, 1999.
30. HEENEY J, AKERBLOM L, BARNETT S, BOGERS W, DAVIS D, FULLER D, KOOPMAN G, LEHNER T, MOOIJ P, MOREIN B, MORGHEN CG, ROSENWIRTH B, VERSCHOOR E, WAGNER R, WOLF H: HIV-1 vaccine induced immune responses which correlate with protection from SHIV infection: Compiled preclinical efficacy data from trials with 10 different HIV-1 vaccine candidates. Immunol Letters 66:189-195, 1999.
31. HEENEY JL, VAN GILS ME, VAN DER MEIDE P, DE GIULI MORGHEN C, GHIONI C, GIMELLI M, RADDELLI A, DAVIS D, AKERBLOM L, MOREIN B: The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection. J Med Primatol 27:50-58, 1998.
32. HU S-L, KLANIECKI J, TRAVIS BM, WREY T, PENNATHUR S, MONTEFIORI DC, THOMPSON JL, AGY MB, KULLER L, MORTON WR: Immunization with HIV-1 gp160 by the 'prime and boost' regimen protects macaques against SHIV HXBc2 challenge. In: Vaccines 97, Molecular Approaches to the Control of Infectious Diseases. Cold Spring Harbor Laboratory Press: New York 291-298, 1997.
33. HULSKOTTE EGJ, GERETTI A-M, OSTERHAUS ADME: Towards an HIV-1 vaccine: lessons from studies in macaque models. Vaccine 16:904-915, 1998.
34. IGARASHI T, AMI Y, YAMAMOTO H, SHIBATA R, KUWATA T, MUKAI R, SHINOHARA K, KOMATSU T, ADACHI A, HAYAMI M: Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live attenuated human AIDS vaccine. J Gen Virol 78:985-989, 1997.
35. JOAG SV, ADANY I, LI Z, FORESMAN L, PINSON DM, WANG C, STEPHENS EB, RAGHAVAN R, NARAYAN O: Animal model of mucosally transmitted HIV-1 disease: intravaginal and oral deposition of SHIV in macaques results in systemic infection, elimination of CD4 T cells, and AIDS. J Virol 71:4016-4023, 1997.
36. JOAG SV, LIU ZQ, STEPHENS EB, SMITH MS, KUMAR A, LI Z, WANG C, SHEFFER D, JIA F, FORESMAN L, ADANY I, LIFSON J, MCCLURE HM, NARAYAN O: Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS. J Virol 72:9069-9078, 1998.
37. KAWABATA S, MILLER CJ, LEHNER T, FUJIHASHI K, KUBOTA M, MCGHEE JR, IMAOKA K, HIROI T, KIYONO H: Induction of Th2 cytokine expression for p27-specific IgA B cell responses after targeted lymph node immunization with simian immunodeficiency virus antigens in rhesus macaques. J Infect Dis 177:26-33, 1998.
38. KENT SJ, ZHAO A, BEST SJ, CHANDLER JD, BOYLE DB, RAMSHAW IA: Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J Virol 72:10180-10188, 1998.
39. KRAISELBURD EN, SALAMAN A, BELTRAN M, RIVERA M, OLIVER J, KESSLER M, KNEZEVICH M, RODRIGUEZ A, BILSKA M, MONTEFIORI D, TORRES-BAUZA LJ, MARTINEZ I: Vaccine evaluation studies of replication-defective SIVsmB7. Cell Mol Biol 43:915-924, 1997.
40. LETVIN NL, MONTEFIORI DC, YASUTOMI Y, PERRY HC, DAVIES M-E, LEKUTIS C, ALROY M, FREED DC, LORD CI, HANDT LK, LIU MA, SHIVER JW: Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci 94:9378-9383, 1997.
41. LINHART H, GUNDLACH BR, SOPPER S, DITUMER U, MATZ-RENSING K, KUHN E-M, KAUP F-J, MULLER J, HUNSMANN G, STAHL-HENNIG C, UBERLA K: Live attenuated SIV vaccines are not effective in a postexposure vaccination model. AIDS Res Hum Retroviruses 13:593-599, 1997.
42. LOCHER CP, BLACKBOURN DJ, BARNETT SW, MURTHY KK, COBB EK, ROUSE S, GRECO G, REYES-TERAN G, BRASKY KM, CAREY KD, LEVY JA: Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 cell antiviral response. J Infect Dis 176:948-959, 1997.
43. LOONEY DJ, MCCLURE J, KENT SJ, RADAELLI A, KRAUS G, SCHMIDT A, STEFFY K, GREENBERG P, HU S-L, MORTON WR, WONG-STAAL F: A minimally replicative HIV-2 live-virus vaccine protects M. nemistrina from disease after HIV-2/287 challenge. Virology 242:150-160, 1998.
44. LU Y, BROSIO P, LAFAILE M, LI J, COLLMAN RG, SODROSKI J, MILLER CJ: Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques. J Virol 70:3045-3050, 1996.
45. LU X, KIYONO H, LU D, KAWABATA S, TORTEN J, SRINIVASAN S, DAILEY PJ, MCGHEE JR, LEHNER T, MILLER CJ: TILN immunization with whole inactivated SIV or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251. AIDS 12:1-10, 1998.
46. LUBECK MD, NATUK R, MYAGKIKH M, KALYAN N, ALDRICH K, SINANGIL F, ALIPANAH S, MURTHY SCS, CHANDA PK, NIGIDA JR SM, MARKHAM PD, ZOLLA-PAZNER S, STEIMER K, WADE M, REITZ JR MS, ARTHUR LO, MIZUTANI S, DAVIS A, HUNG PP, GALLO RC, EICHBERG J, ROBERT-GUROFF M: Long-term protection of chimpanzees against high dose HIV-1 challenge induced by immunization. Nat Med 3:651-658, 1997.
47. MATANO T, SHIBATA R, SIEMON C, CONNORS M, LANE HC, MARTIN MA: Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 72:164-169, 1998.
48. MILLER CJ, MCCHESNEY MB, LU X, DAILEY PJ, CHUTKOWSKI C, LU D, BROSIO P, ROBERTS P, LU Y: Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol 71:1911-1921, 1997.
49. MOOIJ P, VAN DER KOLK M, BOGERS WMJM, TEN HAAFT PJF, VAN DER MEIDE P, ALMOND N, STOTT J, DESCHAMPS M, LABBE D, MOMIN P, VOSS G, VON HOEGEN P, HEENEY JL: A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection. AIDS 12:F15-F22, 1998.
50. MORTARA L, LETOURNEUR F, GRAS-MASSE H, VENET A, GUILLET J-G, BOURGAULT-VILLADA I: Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine. J Virol 72:1403-1410, 1998.
51. MURPHEY-CORB M, WILSON LA, TRICHEL AM, ROBERTS DE, XU K, OHKAWA S, WOODSON B, BOHM R, BLANCHARD J: Selective induction of protective MHC class I restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J Immunol 162:540-549, 1999.
52. MURTHY KK, COBB EK, ROUSE SR, MCCLURE HM, PAYNE JS, SALAS MT, MICHALEK GR: Active and passive immunization against HIV type 1 infection in chimpanzees. AIDS Res Hum Retroviruses 14(Suppl 3):S271-S276, 1998.
53. MURTHY KK, COBB EK, ROUSE SR, LUNCEFORD SM, JOHNSON DE, GALVAN AR: Correlates of protective immunity against HIV infection in immunized chimpanzees. Immunol Letters 51:121-124, 1996.
54. NATHANSON N: Harnessing research to control AIDS. Nat Med 4:879-881, 1998.
55. NILSSON C, MAKITALO B, THORSTENSSON R, NORLEY S, BINNINGER-SCHINZEL D, CRANAGE M, RUD E, BIBERFELD G, PUTKONEN P: Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS 12:2261-2270, 1998.
56. POLACINO P, STALLARD V, KLANIECKI JE, MONTEFIORI DC, LANGLOIS AJ, RICHARDSON BA, OVERBAUGH J, MORTON WR, BENVENISTE RE, HU S-L: Limited breadth of protective immunity elicited by SIVmne gp160 vaccines in a combination immunization regimen. J Virol 73:618-630, 1999.
57. POLYANSKAYA N, SHARPE S, COOK N, LEECH S, BANKS J, DENNIS M, HALL G, STOTT J, CRANAGE M: Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection. AIDS Res Hum Retroviruses 13:923-931, 1997.
58. RADAELLI A, KRAUS G, SCHMIDT A, BADEL P, MCCLURE J, HU S-L, MORTON WR, MORGHEN CDG, WONG-STAAL F, LOONEY D: Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemistrina vaccine model. J Virol 72:7871-7884, 1998.
59. ROBERT-GUROFF M, KAUR H, PATTERSON LJ, LENO M, CONLEY AJ, MCKENNA PM, MARKHAM PD, RICHARDSON E, ALDRICH K, ARORA K, MURTY L, CARTER L, ZOLLA-PAZNER S, SINANGIL F: Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus. J Virol 72:10275-10280, 1998.
60. SHARPE SA, WHATMORE AM, HALL GA, CRANAGE MP: Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus. J Gen Virol 78:1923-1927, 1997.
61. SHIBATA R, SIEMON C, CZAJAK SC, DESROSIERS RC, MARTIN MA: Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J Virol 71:8141-8148, 1997.
62. STEBBINGS R, STOTT J, ALMOND N, HULL R, LINES J, SILVERA P, SANGSTER R, CORCORAN T, ROSE J, COBBOLD S, GOTCH F, MCMICHAEL A, WALKER B: Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abbrogate protection. AIDS Res Hum Retroviruses 14:1187-1198, 1998.
63. STEPHENS EB, JOAG SV, ATKINSON B, SAHNI M, LI Z, FORESMAN L, ADANY I, NARAYAN O: Infected macaques that controlled replication of SIVmac or non-pathogenic SHIV developed sterilizing resistance against pathogenic SHIV KU-1. Virology 234:328-339, 1997.
64. STOTT EJ, ALMOND N, KENT K, WALKER B, HULL R, ROSE J, SILVERA P, SANGSTER R, CORCORAN T, LINES J, SILVERA K, LUCIW P, MURPHY-CORB M, MOMIN P, BRUCK C: Evaluation of candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous SIV/HIV-1 chimeric virus. J Gen Virol 79:423-432, 1998.
65. VAN ROMPAY KKA, BERARDI CJ, DILLARD-TELM S, TARARA RP, CANFIELD DR, VALVERDE CR, MONTEFIORI DC, COLE KS, MONTELARO RC, MILLER CJ, MARTHAS ML: Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis 177:1247-1259, 1998.
66. VOGEL TU, FOURNIER J, SHERRING A, KO D, PARENTEAU M, BOGDANOVIC D, MIHOWICH J, RUD E: Presence of circulating CTL induced by infection with wild-type or attenuated SIV and their correlation with protection from pathogenic SHIV challenge. J Med Primatol 27:65-72, 1998.
67. VOGT G, LE GRAND R, VASLIN B, BOUSSIN F, BAYON AUBOYER M-MB, RIVIERE Y, PUTKONEN P, SONIGO P, KIENY M-P, GIRARD M, DORMONT D: Heterologous HIV-2 challenge of rhesus monkeys immunized with recombinant vaccinia viruses and purified recombinant HIV-2 proteins. Vaccine 13:202-208, 1995.
68. WAGNER R, TEEUWSEN VJP, DEML L, NOTKA F, HAAKSMA GM, JHAGJHOORSINGH SS, NIPHUIS H, WOLF H, HEENEY JL: Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection. Virology 245:65-74, 1998.
69. WARREN JT, LEVINSON MA: Preclinical AIDS vaccine development: formal survey of global HIV, SIV, and SHIV in vivo challence studies in vaccinated nonhuman primates. J Med Primatol 26:63-81, 1997.
70. WARREN JT, LEVINSON MA: Fourth annual survey of world-wide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates. J Med Primatol 24:150-168, 1995.
71. WYAND MS, MANSON KH, LACKNER AA, DESROSIERS RC: Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nat Med 3:32-36, 1997.
72. YASUTOMI Y, KOENIG S, WOODS RM, MADSEN J, WASSEF NM, ALVING CR, KLEIN HJ, NOLAN TE, BOOTS LJ, KESSLER JA, EMINI EA, CONLEY AJ, LETVIN NL: A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. J Virol 69:2279-2284, 1995.
73. ZOLLA-PAZNER S, LUBECK MD, XU S, BURDA S, NATUK RJ, SINANGIL F, GALLO RC, EICHBERG JW, MATTHEWS T, ROBERT-GUROFF M: Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees. J Virol 72:1052-1059, 1998.